CDMO
$6.99
Avid Bioservices
($.32)
(4.38%)
CDMO
Earnings Whisper ®
N/A
2nd Quarter October 2020
Consensus:  $0.00
Revenue:  N/A
Tuesday
Dec 1
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CDMO reports earnings?
Beat
Meet
Miss

Where is CDMO's stock price going from here?
Up
Flat
Down
Stock chart of CDMO
Analysts
Summary of analysts' recommendations for CDMO
Score
Grade
Pivots
Resistance
$7.74
$7.55
$7.27

$7.08

Support
$6.80
$6.61
$6.33
Tweet
Growth
Description
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.